Status:
COMPLETED
Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma
Lead Sponsor:
Azienda Ospedaliera San Giovanni Battista
Conditions:
Multiple Myeloma
Allogeneic Transplantation
Eligibility:
All Genders
18-80 years
Brief Summary
Autologous hematopoietic cell transplantation is currently considered the standard therapy of multiple myeloma (MM) for elegible patients. On the contrary, despite new developments in transplant proce...
Eligibility Criteria
Inclusion
- Multiple myeloma patients treated with allogeneic bone marrow transplantation from unrelated donors (from 2000 to 2009: Centri Trapianto GITMO)
Exclusion
- No exclusion criteria
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT01440556
Start Date
October 1 2011
End Date
January 1 2013
Last Update
July 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
A.O.U.San Giovanni Battista di Torino
Torino, Italy, 10126